Evaluation of the Efficacy of a New Formula in Infants With Cow's Milk Protein Allergy
Not Applicable
Completed
- Conditions
- Milk HypersensitivityProtein AllergyFood Sensitivity
- Interventions
- Dietary Supplement: extensively hydrolyzed rice protein formula
- Registration Number
- NCT01998074
- Lead Sponsor
- United Pharmaceuticals
- Brief Summary
The aim of the study is to show the efficacy, tolerance and nutritional adequacy of a newly developed hydrolyzed rice formula in infants with a proven cow's milk protein allergy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Infants between 2 weeks and 6 months old
- In whom cow's Milk Protein Allergy has been proved by a food challenge performed during the previous month
Exclusion Criteria
- Exclusively breast fed infants
- Preterm infants
- Infants already fed with an extensively hydrolyzed formula with no improvement of the symptoms.
- Infants fed an amino acid based formula
- Infants who had an anaphylactic reaction in the past
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Study formula extensively hydrolyzed rice protein formula -
- Primary Outcome Measures
Name Time Method Clinical improvement of symptoms of cow's milk protein allergy, through the use of a validated score at 4 weeks
- Secondary Outcome Measures
Name Time Method Clinical improvement of symptoms of cow's milk protein allergy, through the use of a validated score at 6 months Growth (weight, height, head circumference) 6 months
Trial Locations
- Locations (1)
Universitair Ziekenhuis
🇧🇪Brussel, Belgium